Reconstitution of the ancestral glycoprotein of human endogenous retrovirus K and modulation of its functional activity by truncation of the cytoplasmic domain

Journal of Virology

Volumn 83, Issue 24, 2009, Pages 12790-12800

  Hanke, Kirsten ^a   Kramer, Philipp ^a   Seeher, Sandra ^a   Beimforde, Nadine ^a,b   Kurth, Reinhard ^a   Bannert, Norbert ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; GLYCOPROTEIN; GLYCOPROTEIN GP 95; MEMBRANE PROTEIN; OLIGOSACCHARIDE; PROTEIN PRECURSOR; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL MIGRATION; CELL STRAIN HEK293; CODON; CYTOPLASM; FEMALE; GENE DELETION; HELA CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LENTIVIRINAE; MOLECULAR WEIGHT; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; RETROVIRUS; VIRION; VIRUS PARTICLE;

AMINO ACID SEQUENCE; ANIMALS; CELLS, CULTURED; CYTOPLASM; ENDOGENOUS RETROVIRUSES; GLYCOPROTEINS; GLYCOSYLATION; HUMANS; MOLECULAR SEQUENCE DATA; STRUCTURE-ACTIVITY RELATIONSHIP; VIRAL ENVELOPE PROTEINS;

HUMAN ENDOGENOUS RETROVIRUS K; MAMMALIA;

EID: 72849127084     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01368-09     Document Type: Article

References (56)

1. Arnaud, F., M. Varela, T. E. Spencer, and M. Palmarini. 2008. Coevolution of endogenous betaretroviruses of sheep and their host. Cell Mol. Life Sci. 65:3422-3432.
2. Bannert, N., and R. Kurth. 2006. The evolutionary dynamics of human endogenous retroviral families. Annu. Rev. Genomics Hum. Genet. 7:149-173.
3. Bannert, N., D. Schenten, S. Craig, and J. Sodroski. 2000. The level of CD4 expression limits infection of primary rhesus monkey macrophages by a T-tropic simian immunodeficiency virus and macrophagetropic human immunodeficiency viruses. J. Virol. 74:10984-10993. (Pubitemid 32223963)
4. Barbulescu, M., G. Turner, M. I. Seaman, A. S. Deinard, K. K. Kidd, and J. Lenz. 1999. Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. Curr. Biol. 9:861-868.
5. Beimforde, N., K. Hanke, I. Ammar, R. Kurth, and N. Bannert. 2008. Molecular cloning and functional characterization of the human endogenous retrovirus K113. Virology 371:216-225.
6. Belshaw, R., A. L. Dawson, J. Woolven-Allen, J. Redding, A. Burt, and M. Tristem. 2005. Genomewide screening reveals high levels of insertional polymorphism in the human endogenous retrovirus family HERV-K(HML2): implications for present-day activity. J. Virol. 79:12507-12514. (Pubitemid 41346113)
7. Belshaw, R., V. Pereira, A. Katzourakis, G. Talbot, J. Paces, A. Burt, and M. Tristem. 2004. Long-term reinfection of the human genome by endogenous retroviruses. Proc. Natl. Acad. Sci. USA 101:4894-4899.
8. Bieda, K., A. Hoffmann, and K. Boller. 2001. Phenotypic heterogeneity of human endogenous retrovirus particles produced by teratocarcinoma cell lines. J. Gen. Virol. 82:591-596.
9. Blot, V., S. Lopez-Verges, M. Breton, C. Pique, C. Berlioz-Torrent, and M. P. Grange. 2006. The conserved dileucine- and tyrosine-based motifs in MLV and MPMV envelope glycoproteins are both important to regulate a common Env intracellular trafficking. Retrovirology 3:62.
10. Boeke, M., and J. P. Stoye. 1997. Retrotransposons, endogenous retroviruses and the evolution of retroelements., p. 343-436. In S. H. H. J. M. Coffin, and H. E. Varmus (ed.), Retroviruses. Cold Spring Harbor Laboratory Press, Plainview, NY.
11. Boller, K., K. Schonfeld, S. Lischer, N. Fischer, A. Hoffmann, R. Kurth, and R. R. Tonjes. 2008. Human endogenous retrovirus HERV-K113 is capable of producing intact viral particles. J. Gen. Virol. 89:567-572.
12. Buzdin, A., S. Ustyugova, K. Khodosevich, I. Mamedov, Y. Lebedev, G. Hunsmann, and E. Sverdlov. 2003. Human-specific subfamilies of HERV-K (HML-2) long terminal repeats: three master genes were active simultaneously during branching of hominoid lineages. Genomics 81:149-156. (Pubitemid 36298606)
13. Celma, C. C., M. G. Paladino, S. A. Gonzalez, and J. L. Affranchino. 2007. Importance of the short cytoplasmic domain of the feline immunodeficiency virus transmembrane glycoprotein for fusion activity and envelope glycoprotein incorporation into virions. Virology 366:405-414.
14. Cheynet, V., A. Ruggieri, G. Oriol, J. L. Blond, B. Boson, L. Vachot, B. Verrier, F. L. Cosset, and F. Mallet. 2005. Synthesis, assembly, and processing of the Env ERVWE1/syncytin human endogenous retroviral envelope. J. Virol. 79:5585-5593. (Pubitemid 40548227)
15. Cote, M., Y. M. Zheng, L. M. Albritton, and S. L. Liu. 2008. Fusogenicity of Jaagsiekte sheep retrovirus envelope protein is dependent on low pH and is enhanced by cytoplasmic tail truncations. J. Virol. 82:2543-2554. (Pubitemid 351293554)
16. Dash, B., A. McIntosh, W. Barrett, and R. Daniels. 1994. Deletion of a single N-linked glycosylation site from the transmembrane envelope protein of human immunodeficiency virus type 1 stops cleavage and transport of gp160 preventing env-mediated fusion. J. Gen. Virol. 75:1389-1397.
17. Demirov, D. G., and E. O. Freed. 2004. Retrovirus budding. Virus Res. 106:87-102.
18. Deml, L., A. Bojak, S. Steck, M. Graf, J. Wild, R. Schirmbeck, H. Wolf, and R. Wagner. 2001. Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein. J. Virol. 75:10991-11001. (Pubitemid 33031566)
19. de Parseval, N., V. Lazar, J. F. Casella, L. Benit, and T. Heidmann. 2003. Survey of human genes of retroviral origin: identification and transcriptome of the genes with coding capacity for complete envelope proteins. J. Virol. 77:10414-10422.
20. Dewannieux, M., S. Blaise, and T. Heidmann. 2005. Identification of a functional envelope protein from the HERV-K family of human endogenous retroviruses. J. Virol. 79:15573-15577. (Pubitemid 43032339)
21. Dewannieux, M., F. Harper, A. Richaud, C. Letzelter, D. Ribet, G. Pierron, and T. Heidmann. 2006. Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements. Genome Res. 16:1548-1556. (Pubitemid 44878493)
22. Edwards, T. G., S. Wyss, J. D. Reeves, S. Zolla-Pazner, J. A. Hoxie, R. W. Doms, and F. Baribaud. 2002. Truncation of the cytoplasmic domain induces exposure of conserved regions in the ectodomain of human immunodefi- ciency virus type 1 envelope protein. J. Virol. 76:2683-2691.
23. Fenouillet, E., J. C. Gluckman, and I. M. Jones. 1994. Functions of HIV envelope glycans. Trends Biochem. Sci. 19:65-70.
24. Freed, E. O., and M. A. Martin. 1995. Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix. J. Virol. 69:1984-1989.
25. Gifford, R., P. Kabat, J. Martin, C. Lynch, and M. Tristem. 2005. Evolution and distribution of class II-related endogenous retroviruses. J. Virol. 79: 6478-6486. (Pubitemid 40617251)
26. Goodman, L. J., S. R. Kain, and G. L. Firestone. 1993. Trafficking of wild-type and an endoproteolytic-site mutant of the mouse mammary tumor virus glycoprotein. J. Biol. Chem. 268:2329-2336.
27. Green, N., T. M. Shinnick, O. Witte, A. Ponticelli, J. G. Sutcliffe, and R. A. Lerner. 1981. Sequence-specific antibodies show that maturation of Moloney leukemia virus envelope polyprotein involves removal of a COOH-terminal peptide. Proc. Natl. Acad. Sci. USA 78:6023-6027.
28. Hakim, S. T., M. Alsayari, D. C. McLean, S. Saleem, K. C. Addanki, M. Aggarwal, K. Mahalingam, and O. Bagasra. 2008. A large number of the human microRNAs target lentiviruses, retroviruses, and endogenous retroviruses. Biochem. Biophys. Res. Commun. 369:357-362.
29. Heslin, D. J., P. Murcia, F. Arnaud, K. Van Doorslaer, M. Palmarini, and J. Lenz. 2009. A single amino acid substitution in a segment of the CA protein within Gag that has similarity to human immunodeficiency virus type 1 blocks infectivity of a human endogenous retrovirus K provirus in the human genome. J. Virol. 83:1105-1114.
30. Hughes, J. F., and J. M. Coffin. 2005. Human endogenous retroviral elements as indicators of ectopic recombination events in the primate genome. Genetics 171:1183-1194.
31. Hughes, J. F., and J. M. Coffin. 2004. Human endogenous retrovirus K solo-LTR formation and insertional polymorphisms: implications for human and viral evolution. Proc. Natl. Acad. Sci. USA 101:1668-1672.
32. Hunter, E., and R. Swanstrom. 1990. Retrovirus envelope glycoproteins. Curr. Top. Microbiol. Immunol. 157:187-253.
33. Jha, A. R., S. K. Pillai, V. A. York, E. R. Sharp, E. C. Storm, D. J. Wachter, J. N. Martin, S. G. Deeks, M. G. Rosenberg, D. F. Nixon, and K. E. Garrison. 2009. 371 cross sectional dating of novel haplotypes of HERV-K 113 and HERV-K 115 indicate these proviruses originated in Africa before Homo sapiens. Mol. Biol. Evol. doi:10.1093/molbev/msp180.
34. Johnston, P. B., J. W. Dubay, and E. Hunter. 1993. Truncations of the simian immunodeficiency virus transmembrane protein confer expanded virus host range by removing a block to virus entry into cells. J. Virol. 67:3077-3086.
35. Katzourakis, A., A. Rambaut, and O. G. Pybus. 2005. The evolutionary dynamics of endogenous retroviruses. Trends Microbiol. 13:463-468.
36. Kayman, S. C., R. Kopelman, S. Projan, D. M. Kinney, and A. Pinter. 1991. Mutational analysis of N-linked glycosylation sites of Friend murine leukemia virus envelope protein. J. Virol. 65:5323-5332.
37. Kim, F. J., N. Manel, Y. Boublik, J. L. Battini, and M. Sitbon. 2003. Human T-cell leukemia virus type 1 envelope-mediated syncytium formation can be activated in resistant mammalian cell lines by a carboxy-terminal truncation of the envelope cytoplasmic domain. J. Virol. 77:963-969.
38. Kowalski, M., J. Potz, L. Basiripour, T. Dorfman, W. C. Goh, E. Terwilliger, A. Dayton, C. Rosen, W. Haseltine, and J. Sodroski. 1987. Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1. Science 237:1351-1355. (Pubitemid 17134619)
39. Lee, Y. N., and P. D. Bieniasz. 2007. Reconstitution of an infectious human endogenous retrovirus. PLoS Pathog. 3:e10.
40. Lee, Y. N., M. H. Malim, and P. D. Bieniasz. 2008. Hypermutation of an ancient human retrovirus by APOBEC3G. J. Virol. 82:8762-8770.
41. Macfarlane, C., and P. Simmonds. 2004. Allelic variation of HERV-K(HML-2) endogenous retroviral elements in human populations. J. Mol. Evol. 59:642-656.
42. Mager, D. L., and P. Medstrand. 2003. Retroviral repeat sequences, p. 57-63. In D. N. Cooper (ed.), Nature encyclopedia of the human genome. Nature Pub. Group, London, United Kingdom.
43. Manrique, J. M., C. C. Celma, E. Hunter, J. L. Affranchino, and S. A. Gonzalez. 2003. Positive and negative modulation of virus infectivity and envelope glycoprotein incorporation into virions by amino acid substitutions at the N terminus of the simian immunodeficiency virus matrix protein. J. Virol. 77:10881-10888.
44. Mayer, J., T. Stuhr, K. Reus, E. Maldener, M. Kitova, F. Asmus, and E. Meese. 2005. Haplotype analysis of the human endogenous retrovirus locus HERV-K(HML-2.HOM) and its evolutionary implications. J. Mol. Evol. 61:706-715.
45. Megati, S., D. Garcia-Hand, S. Cappello, V. Roopchand, A. Masood, R. Xu, A. Luckay, S. Y. Chong, M. Rosati, S. Sackitey, D. B. Weiner, B. K. Felber, G. N. Pavlakis, Z. R. Israel, L. R. Smith, J. H. Eldridge, M. K. Sidhu, and M. A. Egan. 2008. Modifying the HIV-1 env gp160 gene to improve pDNA vaccine-elicited cell-mediated immune responses. Vaccine 26:5083-5094.
46. Mulligan, M. J., G. V. Yamshchikov, G. D. Ritter, Jr., F. Gao, M. J. Jin, C. D. Nail, C. P. Spies, B. H. Hahn, and R. W. Compans. 1992. Cytoplasmic domain truncation enhances fusion activity by the exterior glycoprotein complex of human immunodeficiency virus type 2 in selected cell types. J. Virol. 66:3971-3975.
47. Pinter, A., W. J. Honnen, and J. S. Li. 1984. Studies with inhibitors of oligosaccharide processing indicate a functional role for complex sugars in the transport and proteolysis of Friend mink cell focus-inducing murine leukemia virus envelope proteins. Virology 136:196-210.
48. Puffer, B. A., S. Pohlmann, A. L. Edinger, D. Carlin, M. D. Sanchez, J. Reitter, D. D. Watry, H. S. Fox, R. C. Desrosiers, and R. W. Doms. 2002. CD4 independence of simian immunodeficiency virus Envs is associated with macrophage tropism, neutralization sensitivity, and attenuated pathogenicity. J. Virol. 76:2595-2605.
49. Quinones-Kochs, M. I., L. Buonocore, and J. K. Rose. 2002. Role of N-linked glycans in a human immunodeficiency virus envelope glycoprotein: effects on protein function and the neutralizing antibody response. J. Virol. 76:4199-4211.
50. Reus, K., J. Mayer, M. Sauter, H. Zischler, N. Muller-Lantzsch, and E. Meese. 2001. HERV-K(OLD): ancestor sequences of the human endogenous retrovirus family HERV-K(HML-2). J. Virol. 75:8917-8926. (Pubitemid 32851896)
51. Ritter, G. D., Jr., M. J. Mulligan, S. L. Lydy, and R. W. Compans. 1993. Cell fusion activity of the simian immunodeficiency virus envelope protein is modulated by the intracytoplasmic domain. Virology 197:255-264. (Pubitemid 23313553)
52. Tarlinton, R. E., J. Meers, and P. R. Young. 2006. Retroviral invasion of the koala genome. Nature 442:79-81.
53. Tonjes, R. R., C. Limbach, R. Lower, and R. Kurth. 1997. Expression of human endogenous retrovirus type K envelope glycoprotein in insect and mammalian cells. J. Virol. 71:2747-2756.
54. Turner, G., M. Barbulescu, M. Su, M. I. Jensen-Seaman, K. K. Kidd, and J. Lenz. 2001. Insertional polymorphisms of full-length endogenous retroviruses in humans. Curr. Biol. 11:1531-1535.
55. Vigerust, D. J., and V. L. Shepherd. 2007. Virus glycosylation: role in virulence and immune interactions. Trends Microbiol. 15:211-218.
56. Wyss, S., A. S. Dimitrov, F. Baribaud, T. G. Edwards, R. Blumenthal, and J. A. Hoxie. 2005. Regulation of human immunodeficiency virus type 1 envelope glycoprotein fusion by a membrane-interactive domain in the gp41 cytoplasmic tail. J. Virol. 79:12231-12241. (Pubitemid 41346084)